Y Biologics
Scope
Date
~
-
Bio & Pharma
Samsung Biologics bags $514 mn CMO contract from US pharma
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...
Apr 28, 2025 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Feb 27, 2025 (Gmt+09:00)
-
Korean stock market
Samsung Biologics shares fly high to be Korea’s third most valuable firm
Samsung Biologics Co., the world’s largest contract drugmaker, has become South Korea’s third most valuable stock on the country’s...
Feb 07, 2025 (Gmt+09:00)
-
Earnings
Samsung Biologics posts record 2024 sales, operating profit as it goes global
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, on Wednesday posted its largest-ever annual sales and operating p...
Jan 22, 2025 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Jan 17, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs $1.4 bn CMO deal with European pharma
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...
Jan 14, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs initial deal with LigaChem Bio on ADC production
Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...
Jan 09, 2025 (Gmt+09:00)
-
Social media
Seoul probes fake online accounts of Hyundai Motor advisor Sung Kim
The Seoul Metropolitan Police Agency has launched an investigation into social media accounts pretending to be Hyundai Motor Group advisor Sung Kim,...
Dec 16, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Nov 20, 2024 (Gmt+09:00)
-
Artificial intelligence
AI startup MarqVision raises $16.5 mn to close Series A round
MarqVision Inc., a startup developing an artificial intelligence-powered intellectual property (IP) protection platform, raised 22 billion won ($16....
Oct 04, 2024 (Gmt+09:00)
-
Bio & Pharma
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
Aug 16, 2024 (Gmt+09:00)
-
Korean stock market
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Aug 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung’s biotech duo on a roll with $1.1 bn CMO order
Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...
Jul 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics targets $1.1 billion in sales with new bio plants
South Korean biopharmaceutical company Lotte Biologics Co. said on Wednesday it is aiming for 1.5 trillion won ($1.1 billion) in annual sales by 203...
Jul 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes windfall gain amid US-China row
SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...
Jun 07, 2024 (Gmt+09:00)
-
Korean chipmakers
Samsung's Jay Y. Lee visits Zeiss to reinforce EUV ties
Samsung Electronics Co. is deepening ties with Zeiss Group, the sole provider of optical systems to the world’s only extreme ultraviolet (EUV)...
Apr 28, 2024 (Gmt+09:00)
-
Electric vehicles
Kia to enter emerging markets with its latest EV5 made in China
Kia Corp., South Korea’s second-largest automaker, plans to enhance its presence in emerging markets with the EV5 compact SUV, the company&rsq...
Apr 10, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Leadership & Management
Jay Y. Lee heads to Middle East, Malaysia for next Samsung takeoff
Samsung Electronics Co. Chairman Jay Y. Lee has embarked on a business trip to the Middle East in his first overseas trip since a South Korean court...
Feb 06, 2024 (Gmt+09:00)
-
Automobiles
Daedong Gear to supply $137mn EV parts to Hyundai
Daedong Gear Co., a powertrain subsidiary of South Korea’s Daedong Group, announced on Thursday that it has won a 183.6 billion won ($137 mill...
Jan 25, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics reaches record-breaking annual orders
Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...
Nov 28, 2023 (Gmt+09:00)
-
Executive reshuffles
Samsung sets up future business planning unit, keeps co-CEO system
Samsung Electronics Co., the world’s largest maker of memory chips and smartphones, is creating a new division tasked with working out future ...
Nov 27, 2023 (Gmt+09:00)
-
Business & Politics
S.Korea-UK upgrade bilateral ties, sign deals on nuclear plants, chips
LONDON – South Korea and the UK have agreed to upgrade their bilateral relationship and closely cooperate in the defense, security and busines...
Nov 22, 2023 (Gmt+09:00)
-
Leadership & Management
Samsung’s Jay Y. Lee heads to Europe for partner meetup, Busan Expo
Samsung Electronics Co. Chairman Jay Y. Lee has embarked on a business trip to Europe as he seeks to tighten cooperation with Samsung’s key bu...
Nov 20, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes new drugmaker acquisitions
BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics partners with Europe's largest VC
Samsung Biologics Co., the world's largest contract drug manufacturer, announced on Tuesday it has teamed up with global biotech venture capitalist ...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung Lee's urges to keep ‘super gap’ in semiconductor technology
Samsung Electronics Co. Chairman Jay Y. Lee on Thursday visited the construction site of the global memory chip giant’s new semiconductor rese...
Oct 19, 2023 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google